Literature DB >> 6162969

Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer?

G R Quinones, T J Rohner, J R Drago, L M Demers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6162969     DOI： 10.1016/s0022-5347(17)55037-5

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

1.  Carcinoma of the prostate.

Authors:  W L Orovan; J E Demaria
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

2.  Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.

Authors:  F M Debruyne; P J van Munster; J C van Groeninghen; W J Kirkels
Journal:  Urol Res       Date:  1984

3.  The effect of rectal examination on serum acid phosphatase levels in benign and malignant prostatic disease.

Authors:  D N Osegbe; G Magoha
Journal:  Postgrad Med J       Date:  1982-12       Impact factor: 2.401

4.  Tissue polypeptide antigen (TPA) and prostatic acid phosphatase in serum of prostatic cancer patients.

Authors:  P R Huber; M Rist; F Hering; C Biedermann; G Rutishauser
Journal:  Urol Res       Date:  1983

5.  Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.

Authors:  P R Huber; T Zaugg; E Linder; V Hagmaier; G Rutishauser
Journal:  Urol Res       Date:  1982

Review 6.  Screening for carcinoma of the prostate: efficacy of available screening tests.

Authors:  I M Thompson; W R Fair
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

Review 7.  Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer.

Authors:  Prosper Kanyong; Sean Rawlinson; James Davis
Journal:  J Cancer       Date:  2016-02-10       Impact factor: 4.207
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.